Prostatis Group LLC Biogen Inc. Transaction History

Prostatis Group LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Mar 23, 2023	SELL	$258.66 - $342.55 $29.1 Million - $38.5 Million	-112,316 Closed	0 $0
Q1 2020 Mar 23, 2023	BUY	$268.85 - $341.04 $3.87 Million - $4.91 Million	14,384 Added 14.69%	112,316 $111 Million
Q4 2019 Mar 23, 2023	BUY	$220.06 - $304.07 $21.6 Million - $29.8 Million	97,932 New	97,932 $101 Million

1,015

126M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.3B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Prostatis Group LLC, based on Form 13F filings with the SEC.

Stay updated on Prostatis Group LLC with notifications on news.